Cilnidipin (Aisa Pharma)

西尼地平 (Aisa Pharma)

Report date: 2024/12/25 11:58:43

Base Information

Drug NameCilnidipin (Aisa Pharma)
Drug Alias NameProferviaAISA-021
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsScleroderma, SystemicRaynaud DiseaseNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAisa Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAisa Pharma Inc
Inactive CompaniesN/A
Active IndicationsScleroderma, SystemicRaynaud DiseaseNeuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A